Ireland -
English -
HPRA (Health Products Regulatory Authority)
equihes 60 mg/ml solution for infusion
b. braun melsungen ag - poly(o-2-hydroxyethyl)starch, sodium chloride, potassium chloride, calcium chloride dihydrate, magnesium chloride hexahydrate, sodium acetate trihydrate, l-malic acid dab - solution for infusion - 60 mg/ml - blood substitutes and plasma protein fractions
Ireland -
English -
HPRA (Health Products Regulatory Authority)
equihes 60 mg/ml solution for infusion
b. braun melsungen ag - poly(o-2-hydroxyethyl)starch, sodium chloride, potassium chloride, calcium chloride dihydrate, magnesium chloride hexahydrate, sodium acetate trihydrate, l-malic acid dab - solution for infusion - 60 mg/ml - blood substitutes and plasma protein fractions
Ireland -
English -
HPRA (Health Products Regulatory Authority)
equihes 100 mg/ml solution for infusion
b. braun melsungen ag - poly(o-2-hydroxyethyl)starch, sodium chloride, potassium chloride, calcium chloride dihydrate, magnesium chloride hexahydrate, sodium acetate trihydrate, l-malic acid dab - solution for infusion - 100 mg/ml - blood substitutes and plasma protein fractions
Ireland -
English -
HPRA (Health Products Regulatory Authority)
equihes 100 mg/ml solution for infusion
b. braun melsungen ag - poly(o-2-hydroxyethyl)starch, sodium chloride, potassium chloride, calcium chloride dihydrate, magnesium chloride hexahydrate, sodium acetate trihydrate, l-malic acid dab - solution for infusion - 100 mg/ml - blood substitutes and plasma protein fractions
Ireland -
English -
HPRA (Health Products Regulatory Authority)
paedisol solution for infusion
fresenius kabi limited - sodium chloride; potassium chloride; calcium chloride dihydrate; magnesium chloride hexahydrate; sodium acetate trihydrate; glucose monohydrate - solution for infusion - 0 gram(s)/litre - solutions affecting the electrolyte balance; electrolytes with carbohydrates
Ireland -
English -
HPRA (Health Products Regulatory Authority)
paedisol solution for infusion
fresenius kabi deutschland gmbh - sodium chloride; potassium chloride; calcium chloride dihydrate; magnesium chloride hexahydrate; sodium acetate trihydrate ; glucose monohydrate - solution for infusion - solutions affecting the electrolyte balance; electrolytes with carbohydrates
Ireland -
English -
HPRA (Health Products Regulatory Authority)
compound sodium lactate solution for infusion bp
baxter healthcare limited - sodium chloride; potassium chloride; calcium chloride dihydrate; sodium lactate - solution for infusion - 0 percent volume/volume - solutions affecting the electrolyte balance; electrolytes
Ireland -
English -
HPRA (Health Products Regulatory Authority)
plasma volume redibag 6 % solution for infusion 6 per cent solution for infusion
baxter healthcare limited - hydroxyethyl starch sodium chloride potassium chloride calcium chloride dihydrate magnesium chloride dihydrate sodium acetate trihydrate - solution for infusion - 6 per cent
Ireland -
English -
HPRA (Health Products Regulatory Authority)
compound sodium lactate solution for infusion bp
baxter holding b.v. - sodium chloride; potassium chloride; calcium chloride dihydrate; sodium lactate - solution for infusion - 3.2 gram(s) - solutions affecting the electrolyte balance; electrolytes
United States -
English -
NLM (National Library of Medicine)
peg-3350, sodium sulfate, sodium chloride, potassium chloride, sodium ascorbate and ascorbic acid- peg-3350, sodium sulfate, sod
teva pharmaceuticals usa, inc. - polyethylene glycol 3350 (unii: g2m7p15e5p) (polyethylene glycol 3350 - unii:g2m7p15e5p), sodium chloride (unii: 451w47iq8x) (chloride ion - unii:q32zn48698), sodium sulfate (unii: 0ypr65r21j) (sodium sulfate anhydrous - unii:36kcs0r750), potassium chloride (unii: 660yq98i10) (potassium cation - unii:295o53k152) - peg-3350, sodium sulfate, sodium chloride, potassium chloride, sodium ascorbate, and ascorbic acid for oral solution is an osmotic laxative indicated for cleansing of the colon as a preparation for colonoscopy in adults. peg-3350, sodium sulfate, sodium chloride, potassium chloride, sodium ascorbate, and ascorbic acid for oral solution is contraindicated in the following conditions: - gastrointestinal (gi) obstruction [see warnings and precautions (5.6)] - bowel perforation [see warnings and precautions (5.6)] - gastric retention - ileus - toxic colitis or toxic megacolon - hypersensitivity to any ingredient in peg-3350, sodium sulfate, sodium chloride, potassium chloride, sodium ascorbate, and ascorbic acid for oral solution [see warnings and precautions (5.10)] risk summary there are no available data on peg-3350, sodium sulfate, sodium chloride, potassium chloride, sodium ascorbate, and ascorbic acid for oral solution in pregnant women to inform a drug-associated risk for adverse developmental